Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Russ Wada
Development of a Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose-Finding Study
Journal of Clinical Pharmacology
Pharmacology
Related publications
Results From the First Multicenter, Open-Label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE)
Clinical Breast Cancer
Cancer Research
Oncology
Fixed-Dose Combination Therapy for the Prevention of Cardiovascular Disease
A Phase 1b/2, Open-Label, Dose-Escalation, and Dose-Confirmation Study of Eribulin Mesilate in Combination With Capecitabine
British Journal of Cancer
Cancer Research
Oncology
A Phase I Dose-Escalation Study of a Biosimilar Trastuzumab in Chinese Metastasis Breast Cancer Patients
SpringerPlus
Multidisciplinary
Cost Analysis Study of Anti-Diabetic Fixed Dose Combination Drugs: An Indian Scenario
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Pharmacokinetic Profile of a Novel Fixed-Dose Combination Tablet of Ibuprofen and Paracetamol
BMC Clinical Pharmacology
Fixed-Dose Combination Therapy for the Prevention of Atherosclerotic Cardiovascular Diseases
Cochrane Database of Systematic Reviews
Synergistically Active and Safe Fixed Dose Combination of Meropenem and Sulbactam
IIOAB Letters
Interferon Beta-1a for the Maintenance of Remission in Patients With Crohn's Disease: Results of a Phase II Dose-Finding Study
BMC Gastroenterology
Medicine
Gastroenterology
